Proteom Capital - using genetic engineering techniques in investment analysis 
 
   
Applying quantitiative econometrics and bioengineering to investment finance 
 
 search Proteom
 
 


  Volatility Strategies: Actual/Pro-Forma Performance

Oct 2002 - Dec 2005*

SP500

F1000

G000

H500**

Annual Return 13.87% 207.34% 16.38% 6.68%
Downside Risk 9.56% 34.15% 4.14% 5.43%
Volatility 14.67% 57.66% 6.83% 13.97%
Beta   0.01 -0.02 -0.43
Sharpe 0.87 3.58 2.24 0.03
Information Ratio   3.25 0.15 -0.14

 Alpha

 

257.54%

15.66%

3.36%

* Results calculated on actual net monthly returns from Oct 2002 - Jun 2004, pro-forma thereafter, except where indicated (** = pro-forma from 1979)
 

 
  Equity Strategies: Actual/ Pro-Forma Performance

 

SP500

A000

A100

B000

B100

D050

D100

Annual Return
Jan 2003 - Dec 2005
12.37% 15.42% 15.20% 21.41% 19.94% 16.68% 7.22%
Annual Return
from inception
9.87% 12.78% 19.07% 18.38% 20.90% 20.03% 8.65%
Downside Risk 9.78% 9.38% 5.20% 8.46% 6.47% 2.96% 3.03%
Volatility 15.11% 15.62% 12.30% 15.94% 14.22% 8.35% 6.62%
Beta   0.95 0.49 0.67 0.59 0.21 0.00
Sharpe 0.25 0.43 1.21 0.77 1.17 1.89 0.67
Information Ratio   0.46 0.87 0.64 0.99 0.87 0.03

 Alpha

 

2.99%

12.49%

9.57%

13.96%

14.44%

4.48%

All results calculated on monthly returns from Jan 2003 to Dec 2004,
net of management and performance fees.
 
 
 
Copyright © 2003-2007 Proteom Capital Management Ltd. All rights reserved.